GLUEMonte Rosa Therapeutics, Inc.

Nasdaq monterosatx.com


$ 5.21 $ -0.05 (-0.95 %)    

Thursday, 09-May-2024 15:59:55 EDT
QQQ $ 441.33 $ 0.96 (0.22 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 520.56 $ 2.98 (0.58 %)
TLT $ 90.69 $ 0.44 (0.49 %)
GLD $ 216.93 $ 3.37 (1.58 %)
$ 5.18
$ 5.24
$ 5.20 x 300
$ 0.00 x 0
$ 5.13 - $ 5.26
$ 2.44 - $ 8.84
137,485
na
311.61M
$ 2.19
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-14-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-16-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-11-2022 03-31-2022 10-Q
10 03-29-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-westport-fuel-systems-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected ...

 monte-rosa-therapeutics-q4-eps-058-misses-033-estimate-cash-balance-of-237m-is-expected-to-provide-cash-runway-into-first-half-of-2026

Monte Rosa Therapeutics (NASDAQ:GLUE) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimat...

 monte-rosa-therapeutics-ai-and-machine-learning-platform-is-adding-significant-value-creation-in-cancer-research-analyst

Wedbush initiates coverage on Monte Rosa Therapeutics. With differentiated lead programs and AI-driven QuEEN platform, the comp...

 wedbush-initiates-coverage-on-monte-rosa-therapeutics-with-outperform-rating-announces-price-target-of-11

Wedbush analyst Robert Driscoll initiates coverage on Monte Rosa Therapeutics (NASDAQ:GLUE) with a Outperform rating and ann...

 veradigm-aehr-test-systems-saratoga-investment-and-other-big-stocks-moving-lower-on-wednesday

U.S. stocks traded slightly higher, with the Dow Jones index gaining over 20 points on Wednesday. Shares of Veradigm Inc. (NA...

 monte-rosa-therapeutics-announced-cash-position-expected-to-fund-operations-into-h1-2026

Monte Rosa Therapeutics (NASDAQ:GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-ba...

 monte-rosa-therapeutics-q3-eps-070-beats-072-estimate-cash-cash-equivalents-restricted-cash-and-marketable-securities-of-183m-sufficient-to-fund-planned-operations-and-capital-expenditures-into-1h-of-2026

Monte Rosa Therapeutics (NASDAQ:GLUE) reported quarterly losses of $(0.70) per share which beat the analyst consensus estimate ...

 monte-rosa-therapeutics-presents-preclinical-data-at-acr-convergence-2023-demonstrating-potential-of-mrt-6160-a-vav1-targeted-molecular-glue-degrader-to-treat-immunological-and-inflammatory-diseases

Data presented support broad potential therapeutic applications of MRT-6160 in a variety of autoimmune and inflammatory disorde...

 jp-morgan-maintains-overweight-on-monte-rosa-therapeutics-lowers-price-target-to-11

JP Morgan analyst Eric Joseph maintains Monte Rosa Therapeutics (NASDAQ:GLUE) with a Overweight and lowers the price target ...

 crude-oil-moves-lower-bank-of-america-profit-beats-expectations

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling around 50 points on Tuesday. The ...

 why-servisfirst-bancshares-shares-are-trading-lower-by-6-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION